196 related articles for article (PubMed ID: 18844676)
1. Quantitative correlation between theoretical molecular descriptors and drug-HSA binding affinities for various cox-2 inhibitors.
Seedher N; Bhatia S; Singh B
Chem Biol Drug Des; 2008 Oct; 72(4):297-302. PubMed ID: 18844676
[TBL] [Abstract][Full Text] [Related]
2. An integrated in silico analysis of drug-binding to human serum albumin.
Estrada E; Uriarte E; Molina E; Simón-Manso Y; Milne GW
J Chem Inf Model; 2006; 46(6):2709-24. PubMed ID: 17125211
[TBL] [Abstract][Full Text] [Related]
3. In silico prediction of drug-binding strengths to human serum albumin.
Colmenarejo G
Med Res Rev; 2003 May; 23(3):275-301. PubMed ID: 12647311
[TBL] [Abstract][Full Text] [Related]
4. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
Gunturi SB; Narayanan R; Khandelwal A
Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
[TBL] [Abstract][Full Text] [Related]
5. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.
Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B
J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067
[TBL] [Abstract][Full Text] [Related]
6. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions.
Deeb O; Rosales-Hernández MC; Gómez-Castro C; Garduño-Juárez R; Correa-Basurto J
Biopolymers; 2010 Feb; 93(2):161-70. PubMed ID: 19785033
[TBL] [Abstract][Full Text] [Related]
7. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
[TBL] [Abstract][Full Text] [Related]
8. QSAR models for the prediction of binding affinities to human serum albumin using the heuristic method and a support vector machine.
Xue CX; Zhang RS; Liu HX; Yao XJ; Liu MC; Hu ZD; Fan BT
J Chem Inf Comput Sci; 2004; 44(5):1693-700. PubMed ID: 15446828
[TBL] [Abstract][Full Text] [Related]
9. Results of molecular docking as descriptors to predict human serum albumin binding affinity.
Chen L; Chen X
J Mol Graph Model; 2012 Mar; 33():35-43. PubMed ID: 22153983
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic and molecular modeling studies on the binding of the flavonoid luteolin and human serum albumin.
Jurasekova Z; Marconi G; Sanchez-Cortes S; Torreggiani A
Biopolymers; 2009 Nov; 91(11):917-27. PubMed ID: 19603495
[TBL] [Abstract][Full Text] [Related]
11. Prediction of blood-brain partitioning and human serum albumin binding based on COSMO-RS sigma-moments.
Wichmann K; Diedenhofen M; Klamt A
J Chem Inf Model; 2007; 47(1):228-33. PubMed ID: 17238268
[TBL] [Abstract][Full Text] [Related]
12. Molecular interaction of human serum albumin with paracetamol: spectroscopic and molecular modeling studies.
Daneshgar P; Moosavi-Movahedi AA; Norouzi P; Ganjali MR; Madadkar-Sobhani A; Saboury AA
Int J Biol Macromol; 2009 Aug; 45(2):129-34. PubMed ID: 19409413
[TBL] [Abstract][Full Text] [Related]
13. Complexation of cox-2 inhibitors with bovine serum albumin: interaction mechanism.
Seedher N; Bhatia S
Pharm Dev Technol; 2009; 14(4):343-9. PubMed ID: 19235548
[TBL] [Abstract][Full Text] [Related]
14. Modeling drug albumin binding affinity with e-state topological structure representation.
Hall LM; Hall LH; Kier LB
J Chem Inf Comput Sci; 2003; 43(6):2120-8. PubMed ID: 14632464
[TBL] [Abstract][Full Text] [Related]
15. Cheminformatic models to predict binding affinities to human serum albumin.
Colmenarejo G; Alvarez-Pedraglio A; Lavandera JL
J Med Chem; 2001 Dec; 44(25):4370-8. PubMed ID: 11728183
[TBL] [Abstract][Full Text] [Related]
16. Flow injection-capillary electrophoresis frontal analysis method for the study of the interactions of a series of drugs with human serum albumin.
Liu X; Li S; Zhang J; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3144-50. PubMed ID: 19695968
[TBL] [Abstract][Full Text] [Related]
17. Studies on the interaction of caffeic acid with human serum albumin in membrane mimetic environments.
Zhang Y; Yue Y; Li J; Chen X
J Photochem Photobiol B; 2008 Mar; 90(3):141-51. PubMed ID: 18243725
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of the drug-binding specificity of human serum albumin.
Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
[TBL] [Abstract][Full Text] [Related]
19. A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.
Zhu L; Yang F; Chen L; Meehan EJ; Huang M
J Struct Biol; 2008 Apr; 162(1):40-9. PubMed ID: 18258455
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationship study of orally active cyclooxygenase-2 (COX-2) inhibitors of derivatives of 3-phenoxypyran-4-one.
Shekhawat M; Singh P; Kumar R
Indian J Biochem Biophys; 2007 Feb; 44(1):50-5. PubMed ID: 17385341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
